Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Infant Development
Total 0 results
Nothing found
Sponsors and Collaborators
Nacuity Pharmaceuticals, Inc.
Hospital Durand, Argentina
ASST Cremona, Cremona
Hospital ASEPEYO Sant Cugat
Korean Society of Spine Surgery
Kupfer, David J., M.D.
RMIT University, Melbourne, Australia
Neurophth Therapeutics Inc
Mª Victoria Maestre Sanchez
Everett Meyer
iCAD
GFI
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Aptis Medical
Agency for Science, Technology and Research
Apollo Neuroscience, Inc.
Alma Lasers Inc.
Eurofins Genoma
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
View Full List
Medical Conditions
Chronic Constipation Symptoms
Gastric Cancer Stage IIIB-IIIC
Immune-Mediated Inflammatory Disease
Recurrent Clear Cell Sarcoma of Soft Tissue
Dienogest
Treatment Decisions
T-LGL Leukemia
The Strength Properties of the Aorta in Vitro
RISS Stage III Plasma Cell Myeloma
Scleredema
Luteal Phase Support
Splenic Trauma
Corneal Cross-Linking
Rheumatoid Arthritis(RA)
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Disorder of Fluid Balance
Major Liver Surgery
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Metachronous Adenoma
Fever
View Full List
Drug Interventions
Standard of care (SOC) for COVID-19
Desvenlafaxine
Capecitabine/cisplatin
GLPG1837 multiple ascending doses
Anticholinergic
Fospropofol disodium, propofol
Capecitabine and IMRT (if randomized to this arm)
Olopatadine
Intravenous Formulation of PD-0332991
THC
OnabotulinumtoxinA
RDX227675
Camptosar
Intravenous deferiprone
PD-1/PD-L1 inhibitor
Letrozole
Midazolam
Oxycodone/acetaminophen 5/325 mg
MLN2480
TPN-101
View Full List
CROs by country
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Jamaica
Contract Research Organizations in Luxembourg
Contract Research Organizations in New Zealand
Contract Research Organizations in Nigeria
Contract Research Organizations in Norway
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Singapore
Contract Research Organizations in Spain
Contract Research Organizations in Togo
Contract Research Organizations in Uruguay
CRO list by country
CROs in Gambia
SGS
All CROs in Gambia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe